Đang chuẩn bị liên kết để tải về tài liệu:
báo cáo khoa học: " Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded | Harm Reduction Journal BioMed Zentral Open Access Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India what has been established needs to be continued and expanded M Suresh Kumar1 Richard D Natale3 B Langkham4 Charan Sharma4 Rachel Kabi4 and Gordon Mortimore 2 5 Address 1Chennai and National Institute of Epidemiology Indian Council of Medical Research Chennai India 2DFID PMO New Delhi 110016 India 3Australia International Health Institute AIHI University of Melbourne Melbourne Australia 4Emmanuel Hospital Association EHA New Delhi India and 5HAARP Regional Technical Coordination Unit Chamnan Phenjati Building 2nd Floor 65 32 Rama 9 Road Huay Kwang Bangkok 10310 Thailand Email M Suresh Kumar - msuresh@vsnl.com Richard D Natale - dinatale@unimeld.edu.au B Langkham - langkham@eha-health.org Charan Sharma - charan_sc@yahoo.co.in Rachel Kabi - orchid@eha-health.org Gordon Mortimore - gordon.mortimore@hlspworldwide.org Corresponding author Published 26 February 2009 Received 2 December 2006 Accepted 26 February 2009 Harm Reduction Journal 2009 6 4 doi 10.1186 1477-7517-6-4 This article is available from http www.harmreductionjournal.cOm content 6 1 4 2009 Kumar et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Manipur and Nagaland in northeast India report an antenatal HIV prevalence of 1 and the current HIV prevalence among injecting drug users is 24 and 4.5 respectively. Through support from DFID s Challenge Fund Emmanuel Hospital Association EHA established thirteen drop-incentres across the two states to deliver opioid substitution treatment with sublingual buprenorphine for 1200 injecting drug users. Within a short span of time the treatment has been found to be